Insights
Our article in Clinical Leader: “Enabling “Good” Clinical Research In LMICs With The Good Clinical Trials Collaborative”
Ee Ching Tan
In August, the Good Clinical Trials Collaborative and four major clinical trials networks unveiled a strategic collaboration aimed at bolstering clinical trials research in low- and middle-income countries. In a new article in Clinical Leader, Nick Medhurst delves into how Good Trials Prism can play…
The Collaborative submits feedback on WHO draft clinical trials guidance
Ee Ching Tan
The Good Clinical Trials Collaborative has submitted feedback on the World Health Organization’s draft clinical trials best practice guidance, in response to its public consultation launched in July 2023.
The Collaborative submits commentary on draft GCP E6(R3) guidelines to regulators
Ee Ching Tan
The Good Clinical Trials Collaborative has submitted commentaries to national regulatory authorities, responding to the public consultation launched by the International Council of Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) in May 2023.
Inside GoodTrials Newsletter – August 2023
Ee Ching Tan
Highlights of this edition include World Health Organization’s public consultation of its draft clinical trials guidance and Professor Sir Martin Landray's participation in NIH Pragmatic Trials Collaboratory's webinar on Friday, 18 August, discussing International Council of Harmonisation’s updated guidelines for Good Clinical Practice.
The Collaborative joins forces with leading clinical trial networks to improve clinical research in low resource settings
Ee Ching Tan
Four major clinical trial networks based in low resource settings and the Good Clinical Trials Collaborative have formed Good Trials Prism - an exciting partnership to enhance clinical research in low resource settings.
WHO seeks public comments on draft clinical trials guidance – the Collaborative’s guidance utilized as key source
Ee Ching Tan
The World Health Organization (WHO) has published its draft guidance for best practices for clinical trials, and is now inviting members of the public to provide their feedback and comments.
Collaborating for success – an interview with Dr. Mo Yin of ADVANCE-ID
Ee Ching Tan
In this instalment of #GoodTrialsGrapevine, Dr. Mo Yin, Deputy Director of ADVANCE-ID, a leading clinical trials network based in Southeast Asia, shares her valuable insights into the benefits of collaboration, including boosting the quality and efficiency of clinical research in the diverse region of Asia.
Inside GoodTrials Newsletter – June 2023
Ee Ching Tan
Highlights of this edition include our community response to ICH's Public Consultation on GCP E6(R3) Guideline and our commentary in Lancet Psychiatry - "Fast tracking informative clinical trials: lessons for mental health".
